GATA6 and neonatal diabetes mellitus: Heterozygous inactivating mutations in GATA6 were identified through a whole exome sequencing strategy in 15/27 (56%) individuals with pancreatic agenesis, defined as NDM requiring insulin treatment and exocrine pancreatic insufficiency requiring enzyme replacement.